GBA Presents: RADIO SAVANT-!


SP500S&P 500 Index 4,012 ------------ GBA Exit # 4,020
the time has come.

$4,012.1254.87(+1.39%)

major announcement! GBA GOES TO HOLD ON STOCKS-! DECLARES END TO STONEY RALLY!!!!

This does not mean we cannot drift higher we can. Just that the easier money has been made.

The old points of resistance are still there S&P 4,200 this is all a redo go way back and we crested 4,200 and failed somewhere near 4,300--

This is when we got you out safely once before.
 
CHILDREN FIND THE EXITS PLEASE.....


Lots of low vol..

KOD @$8.15 was the BP I held off Going to gym and will re look at everything after.


Low Vol.

PENN Entertainment, Inc. (PENN)
NasdaqGS - NasdaqGS Real Time Price.
38.56+0.93(+2.47%)
As of 09:58AM EST.
 
Dentsply Sirona price target lowered to $40 from $51 at Barrington 09:16 XRAY Barrington analyst Michael Petusky lowered the firm's price target on Dentsply Sirona to $40 from $51 and keeps an Outperform rating on the shares post the Q3 results. The analyst anticipated reduced guidance since macro conditions have become more challenging. That said, with the internal investigation completed and remediation efforts underway, "reduced uncertainty somewhat mitigates the more pessimistic" near-term revenue and earnings outlook, Petusky tells investors in a research note.
 
stonedinvestor said:
GBA Adding UiPath Inc. (PATH) @$13.77;)
NYSE - Nasdaq Real Time Price.
13.77+1.72 (+14.27%)
As of 10:03AM EST.
More...



cancelling trade.

Co operating loss $70 mln that is unacceptable in the current market climate.

UiPath reports preliminary Q3 revenue $260M, consensus $245.34M 09:28 PATH In a regulatory filing out earlier, UiPath reported preliminary revenue for Q3 of approximately $260M. Based on preliminary unaudited financial information, the company also expects to report: ARR of approximately $1.108B as of October 31, GAAP operating loss of approximately ($70M), and Non-GAAP operating income of approximately $15M. iPath is scheduled to report results and host its fiscal third quarter 2023 conference call on December 1.
 
stonedinvestor said:
Oct 10th- Stoney nails the uptrend extension.

& gives important sign post.>

Today spends half hour of life re finding post to give vital info again to
Elite Traders.

3,825 <--------- S&P Trigger :wtf:


S&P 500 (^GSPC) Today The Short Covering Part of The stoney rally snaps into place!!!!!
SNP - SNP Real Time Price. Currency in USD
Add to watchlist
3,854.83+47.53(+1.25%)<------------:fistbump:
As of 10:38AM EDT. Market open.
More...





I think that 3825 will call us again here-- from there on was short covering.

I'm going to hit the gym.
 
Damn it I have a tooth problem. When I have a tooth problem it's never simple.
I swear two days ago I get an email that my long time Dentist has retired.

Now with the cold weather I can feel the air going up my tooth and into my brain.
 
stonedinvestor said:
Just going by what you said.



<<2 Possible Gummies>>


Kodiak Sciences initiated with an Overweight at Capital One 08:27 KOD Capital One analyst Zegbeh Jallah initiated coverage of Kodiak Sciences with an Overweight rating and $24 price target. Kodiak's long-acting anti-VEGF drug Tarcocimab, or KSI-301, is currently in Phase 3 studies for DME, wAMD and NPDR with data expected in 2023, Jallah tells investors. Data from the Phase 3 BEACON study presented in September reaffirmed KSI-301's longer-acting potential and clean safety profile and "sets positive expectations for the 2023 readouts," but Jallah believes that macro events affecting the market and a "flight of investors out of the biotech sector" led to a muted reaction to the data, the analyst added.


KOD
$7.25-0.31(-4.10%)11:00 AM 11/14/22
NASDAQ |$USD |Pre-Market:$7.51+0.26(+3.59%)3:48 AM

Small reaction-
/////////////////////
NeuroSense rises 16% on U.S. FDA clearance to begin trial of ALS treatment

Watch For Gummy!// wait for GO TIME<---------:caution::caution::caution::caution::caution:






NRSN
$1.580.06(+4.30%)10:59 AM 11/14/22
NASDAQ |$USD |Pre-Market:$1.74+0.17(+10.48%)<----------:caution:

BUY VAN!!!!!

& Sell! Just made you 5% :D

NRSN NeuroSense Therapeutics Ltd.

$1.580.06(+4.30%)10:59 AM 11/14/22
NASDAQ |$USD |Pre-Market:$1.81+0.24(+14.92%)4:15 AM
More...




NeuroSense Therapeutics Ltd. (NRSN)-- GET Ready!
NasdaqCM - NasdaqCM Real Time Price.
1.6885+0.1085 (+6.87%)<-----------
As of 11:57AM EST. .
 
You must log in or register to reply here.
Back
Top